APA

Zhu L., Hruska M., Hwang C., Shah V., Furlong M., Hanna G. J., Bertz R. & Landry I. S. (20160407). Pharmacokinetic interactions between BMS-626529, the active moiety of the HIV-1 attachment inhibitor prodrug BMS-663068, and ritonavir or ritonavir-boosted atazanavir in healthy subjects. : Antimicrobial agents and chemotherapy.

Chicago

Zhu Li, Hruska Matthew, Hwang Carey, Shah Vaishali, Furlong Michael, Hanna George J, Bertz Richard and Landry Ishani Savant. 20160407. Pharmacokinetic interactions between BMS-626529, the active moiety of the HIV-1 attachment inhibitor prodrug BMS-663068, and ritonavir or ritonavir-boosted atazanavir in healthy subjects. : Antimicrobial agents and chemotherapy.

Harvard

Zhu L., Hruska M., Hwang C., Shah V., Furlong M., Hanna G. J., Bertz R. and Landry I. S. (20160407). Pharmacokinetic interactions between BMS-626529, the active moiety of the HIV-1 attachment inhibitor prodrug BMS-663068, and ritonavir or ritonavir-boosted atazanavir in healthy subjects. : Antimicrobial agents and chemotherapy.

MLA

Zhu Li, Hruska Matthew, Hwang Carey, Shah Vaishali, Furlong Michael, Hanna George J, Bertz Richard and Landry Ishani Savant. Pharmacokinetic interactions between BMS-626529, the active moiety of the HIV-1 attachment inhibitor prodrug BMS-663068, and ritonavir or ritonavir-boosted atazanavir in healthy subjects. : Antimicrobial agents and chemotherapy. 20160407.